tenk.fyi

Silexion Therapeutics Corp

SLXNNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$11.9M

27.9% YoY

EPS

$8.96

97.7% YoY

Cash

$6.0M

404.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro